Revenue
Margin
Demand
Guidance
Tone
Metrics cut 1
- AMCA RFP submission deadline extended by 2 months to August 27, 2026 (deadline deferred)
Event Participants
Executives
3
Damodar Bhattad S, Manoj Jain, S Sreenivas
Analysts
15
Amit Dixit, Aritra Banerjee, Atul Tiwari, Bhalchandra Shinde, Bhavya Gandhi, Dipen Vakil, Hardik Rawat, Harshit Patel, Jyoti Gupta, Kavish Parekh, Mohit Pandey, Rahul, Shriram Kapoor, Vikash Singh, Vipul Kumar Shah
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue from Operations | ₹5,533 crores (Q1 FY27) | +25.27% YoY vs ₹4,417 crores in Q1 FY26; execution across LRSAM, MPR Arudhra, Lynx U2, periscope upgrades, Akash and Himshakti supplies |
| Order Inflow (Q1 FY27) | ₹3,754 crores | Lean vs prior-year Q1; driven by ~₹2,000–3,000 crores pulled forward into Q4 FY26 (FY26 closed at ~₹30,000+ crores vs ~₹25,000 crores planned); FY27 target of ₹55,000+ crores unchanged |
| Order Book (as on July 1, 2026) | ₹72,258 crores | ~30% each Army/Navy/Air Force (90% defence); top 7 projects — Fuzes, LRSAM, LCA Mk1/Mk1A LRUs, BMP-2 upgrade, Ashwini Radar, EW suite Mi-17 V5, MPR Arudhra — account for ~₹20,000+ crores |
| PBT | ₹1,403 crores | +8.81% YoY vs ₹1,289 crores in Q1 FY26 |
| PAT | ₹1,048 crores | +8.17% YoY vs ₹969 crores in Q1 FY26; EPS ₹1.43 vs ₹1.33 |
| EBITDA Margin | 25.83% | Down YoY; management attributes to product mix, not input costs; FY27 guidance of 28% reiterated |
| Receivables Days | ~140 days (June 30, 2026) | Improved from 176 days on March 31, 2026; CFO described cash flows as "good" |
| Employee Cost to Turnover | ~12% | Expected to remain ~12% despite wage revision due from January 1, 2027 |
| Export Order Book | USD465 million | Export leads pursued at 4–5x this book; internal FY27 export target of USD300 million |
Geographic & Segment Commentary
- Defence (Army/Navy/Air Force): ~90% of business, split roughly 30% Army, 30% Navy, 30% Air Force. Major order book components: Electronic Fuzes and BMP-2 upgrade (Army), LRSAM (Navy), LCA LRUs, Ashwini Radar, EW suite Mi-17 V5, MPR Arudhra (Air Force). Management stated margins are uniform across the three forces; no segment-specific margin differential.
- Exports: Export order book of USD465 million with leads 4–5x that amount; key products include next-generation software-defined radios (~₹2,000 crore order received last year), Satcom solutions, D4 counter-drone/DEW systems, and TR modules for airborne platforms. Internal FY27 target: USD300 million; goal of 10% of revenue from exports within 5 years.
- Non-Defence/Diversification: ~10% of business; R&D directed toward civilian domains including Rail, Metro, Aviation, and Space.
Company-Specific & Strategic Commentary
- Indigenization Drive: Target of zero module/sub-module imports (excluding semiconductor components) within next 5 years, including verification, validation, and certification as form-fit replacements; formal indigenization policy to be released; funded through R&D budget, not capex, with special budgets allocated.
- R&D Investment: ₹2,200+ crores allocated for FY27 (currently ~6.5–6.8% of revenue); deployed across AI, radars, sonar, EW, and new civilian segments; management believes higher R&D spend strengthens rather than erodes EBITDA margins through indigenization.
- Counter-Drone/DEW Solutions: Focus on hard-kill D4 solutions (high-power laser and microwave-based directed energy weapons); 2kW laser DEW orders received over last 3 years with ~80% delivered; microwave DEW prototype (jointly developed with DRDO) under evaluation; export demos generated keen interest; startup collaborations underway for smaller D2-type systems.
- AMCA Program: Working jointly with L&T; internal pricing and sub-module clarity largely finalized after two apex-level meetings; RFP submission deadline extended by 2 months to August 27, 2026.
- Missile Programs: BEL entering missile domain; already secured orders as DcPP partner in 2–3 programs collaborating with private players; management positions BEL as leader in complex missile electronics (radars, EW, data links).
- Capex: ₹1,200+ crores planned for FY27 toward production infrastructure and capacity enhancement, kept separate from R&D/indigenization budgets.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Revenue Growth | ~15% for FY27 | Reaffirmed; Q1 grew 25.27% YoY; MD indicated possible upside surprise of 0.5–1.5% |
| EBITDA Margin | 28% for FY27 | CFO reiterated guidance; Q1 at 25.83% due to product mix; MD expects to cross 28% at year-end (quarterly band 25–31%) |
| Order Inflow | ₹55,000+ crores for FY27 | Composition: ~₹30,000 crores QRSAM; ~₹15,000+ crores platform orders — Shatrughat/Samaghat ~₹9,000+ crores (3–6 months), Shakti Phase 4 ~₹2,000 crores, HAMMER ~₹2,500+ crores, NGC/P75I (100% probability of at least one; >50% both); balance from base orders, spares, AMCs, services |
| QRSAM Order | ~₹30,000 crores; expected by September 2026 | All BEL-side inputs/activities complete; awaiting CCS approval; first order spread over 7–8 years due to FOPM evaluation, repeat orders in 3–4 years |
| R&D Investment | ₹2,200+ crores FY27 | For niche technology development, indigenization, collaborative R&D |
| Capex | ₹1,200+ crores FY27 | Production infrastructure and capacity enhancement |
| Exports | USD300 million internal target FY27 | Based on leads 4–5x current export order book; long-term goal 10% of revenue from exports in 5 years |
| Employee Cost | ~12% of turnover | Wage revision provision for 3 months (Jan–Mar FY27); full provision next year if unsettled; expected to be absorbed by growing turnover |
Risks & Constraints
| Risk | Context |
|---|---|
| CCS Approval Delays | QRSAM, NGC, and P75I all await CCS clearance; slippage would push order inflow to next year. Management remains confident — QRSAM by September, at least one of NGC/P75I with >50% probability of both |
| Wage Revision Impact | Effective January 1, 2027 (10-year cycle; last hike January 2017); quantum not yet decided by government committees; FY27 carries 3-month provision; risk if turnover growth does not absorb the increase as expected |
| Tejas/Engine Bottleneck | Media reports indicate engine-driven delays at HAL; BEL has already supplied excess LRUs. Worst-case impact for BEL: ~₹200–300 crores revenue shift by a few months — under 1% of the ₹30,000 crore FY27 execution plan; no slowdown communicated by HAL to date |
| Private Competition | Adani Defence won Netra 2 system integration (BEL bid but was not L1); missile programs (e.g., Astra Mk) opened to private players. BEL retains subsystem positions and leadership in complex electronics, but SI roles will be competed |
| Margin Mix Variability | Quarterly EBITDA margin oscillates 25–31% depending on product mix; raw material cost range of 50–59% of revenue (typical ~55%) can create quarterly noise against the 28% annual guidance |
| Export Conversion | Leads are 4–5x the export order book but conversion timing is unpredictable; internal USD300 million FY27 target depends on order finalization, which management cannot directly predict |
Q&A Highlights
Order Inflow Decline and QRSAM Timing
- Question: Q1 order inflow was lean vs Q1 FY26/Q1 FY25 — is this structural or timing? Also, QRSAM seems delayed. (Amit Dixit, Goldman Sachs)
- Answer: Last year's Q1 benefited from spillover of ~₹2,000–3,000 crores from Jan–Mar; this year Q4 FY26 closed at ₹30,000+ crores vs ~₹25,000 crores planned, so minimal backlog. FY27 order inflow guidance of ₹55,000+ crores stands. QRSAM: all BEL-side activities complete; only CCS approval pending, expected by September 2026. (Manoj Jain)
FY27 Order Pipeline Composition and Sizing
- Question: What is the composition of the ₹55,000 crore order target and which are the key growth drivers, excluding QRSAM? (Dipen Vakil, PhilipCapital; Mohit Pandey, Citi)
- Answer: Of ₹55,000+ crores: ~₹30,000 crores QRSAM; ~₹15,000+ crores platform orders — Shatrughat/Samaghat ~₹9,000+ crores (expected in 3–6 months), Shakti Phase 4 ~₹2,000 crores, HAMMER ~₹2,500+ crores, plus NGC or P75I (at least one near-certain, both >50% probability); remainder from base orders, spares, AMCs. (Manoj Jain)
Q1 Margin Decline and FY27 EBITDA Guidance
- Question: Is the YoY margin decline product mix or input cost/one-offs? Can 28% EBITDA be achieved in remaining quarters? (Mohit Pandey, Citi; Bhavya Gandhi, Bajaj Alternate)
- Answer: Entirely product mix — not input costs. Other expenses fell ~20% YoY because prior-year liquidated damages provisions on delivery schedules did not repeat. Quarterly EBITDA margins vary 25–31%; management reaffirms 28% FY27 guidance and expects to cross it. (Damodar Bhattad; Manoj Jain)
Wage Revision and Employee Cost Outlook
- Question: When will pay commission provisions start, and what is the impact on margins over 2–3 years? (Atul Tiwari, JPMorgan; Rahul, Macquarie)
- Answer: Wage revision effective January 1, 2027 (last hike January 2017, 10-year cycle); FY27 will carry a 3-month provision (Jan–Mar). Exact hike quantum not yet decided (government-level committees). Employee cost-to-turnover expected to remain ~12% as revenue grows at good scale. (Damodar Bhattad)
Indigenization and Cost Inflation Shield
- Question: Do supply chain contracts shield from material cost inflation in FY28–29, and what is the indigenization target? (Vikash Singh, ICICI Securities)
- Answer: The indigenization drive will compensate for material escalations; target is zero module/sub-module imports within 5 years (excluding semiconductor components), including verification/certification. Formal indigenization policy to be released; funded from ₹2,200+ crore R&D budget, while ₹1,200+ crore capex is for capacity. (Manoj Jain)
AMCA and Tejas Program Updates
- Question: What is the AMCA status and new RFP deadline? Can Tejas delivery delays impact BEL's LRU revenue? (Vikash Singh, ICICI Securities; Jyoti Gupta, Ashika Group)
- Answer: AMCA: BEL-L&T internal pricing and sub-module clarity largely finalized; RFP submission extended by 2 months to August 27, 2026. Tejas: BEL has supplied more LRUs than HAL requires — bottleneck is engines, not LRUs; even if HAL slows intake, only ~₹200–300 crores of revenue could shift by a few months (<1% of plan). (Manoj Jain)
LRSAM Execution Schedule
- Question: Why is a sizeable LRSAM order from FY19 still unexecuted? (Aritra Banerjee, Nomura)
- Answer: LRSAM delivery schedule was back-ended; ~₹3,000+ crores remains, of which ~₹2,100–2,200 crores is planned for FY27 with a few hundred crores rolling to FY28 — entirely as per schedule. QRSAM first order spans 7–8 years due to FOPM and evaluations; a repeat order of similar quantity could be delivered in 3–4 years. (Manoj Jain)
Competitive Dynamics: Netra 2 and Missile Privatization
- Question: Adani Defence is SI for Netra 2 — does BEL lose out? How does private entry into missile programs affect BEL? (Harshit Patel, Equirus; Bhalchandra Shinde, Motilal Oswal)
- Answer: BEL bid for Netra 2 but was not L1; DRDO and Adani will still utilize BEL subsystems (radars, EW, data links). Missile demand is large enough for BDL, BEL, and private players; BEL leads in complex missile electronics and is collaborating with private firms as DcPP partner in 2–3 programs. (Manoj Jain)
Exports and DEW/Counter-Drone Commercialization
- Question: Which export markets/products offer the best opportunity? When do DEW prototypes convert to commercial sales? (Rahul, Macquarie; Hardik Rawat, IIFL; Vipul Shah, Sumangal)
- Answer: Export order book USD465 million; leads 4–5x; FY27 internal target USD300 million; focus on software-defined radios, Satcom, D4 solutions, and TR modules; export share goal of 10% in 5 years. DEW: 2kW laser orders secured (80% delivered); microwave prototype (jointly with DRDO) under evaluation; customized export configurations demoed with strong country interest. (Manoj Jain)
Key Takeaway
Bharat Electronics delivered a strong Q1 FY27 with revenue of ₹5,533 crores (+25.27% YoY), PAT of ₹1,048 crores (+8.17% YoY), and an EBITDA margin of 25.83%, while receivables days improved to 140 from 176 in March. Q1 order inflow was lean at ₹3,754 crores, but management attributed this to Q4 FY26 pull-forward and reaffirmed FY27 guidance of 15% revenue growth, 28% EBITDA margin, and ₹55,000+ crores of order inflow — anchored by QRSAM (₹30,000 crores, awaiting CCS approval, expected by September) and platform orders including Shatrughat/Samaghat (₹9,000 crores), HAMMER (₹2,500 crores), and Shakti Phase 4 (~₹2,000 crores). The ₹72,258 crore order book remains balanced across Army, Navy, and Air Force. Strategically, BEL is driving a five-year zero-module-import indigenization program with ₹2,200+ crores of R&D investment, expanding exports (USD300 million FY27 target), and building hard-kill counter-drone/DEW capabilities. Key watch points: CCS clearance timing for marquee programs, wage revision provisions from January 2027, and rising private-sector competition in system integration roles.